Lion Point Capital’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.22M | Sell |
|
|||||
|
2024
Q2 | $2.47M | Sell |
|
|||||
|
2024
Q1 | $19.2M | Sell |
|
|||||
|
2023
Q4 | $23.2M | Sell |
|
|||||
|
2023
Q3 | $17.3M | Sell |
|
|||||
|
2023
Q2 | $24.5M | Sell |
|
|||||
|
2023
Q1 | $18.1M | Sell |
|
|||||
|
2022
Q4 | $21.5M | Buy |
|
|||||
|
2022
Q3 | $19M | Hold |
|
|||||
|
2022
Q2 | $19M | Buy |
|
|||||
|
2022
Q1 | $33.9M | Hold |
|
|||||
|
2021
Q4 | $43.1M | Hold |
|
|||||
|
2021
Q3 | $41.3M | Sell |
|
|||||
|
2021
Q2 | $65.2M | Buy |
|
|||||
|
2021
Q1 | $56M | Hold |
|
|||||
|
2020
Q4 | $44.1M | Buy |
|
|||||
|
2020
Q3 | $34.9M | Sell |
|
|||||
|
2020
Q2 | $27.6M | Buy |
|
|||||
|
2020
Q1 | $12.9M | Hold |
|
|||||
|
2019
Q4 | $13.8M | Buy |
|
|||||
|
2019
Q3 | $5.31M | Buy |
|